Literature DB >> 22658952

The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.

Cleanthe Spanaki1, Ioannis Zaganas, Zuzana Kounoupa, Andreas Plaitakis.   

Abstract

Mammalian glutamate dehydrogenase (GDH) is a housekeeping mitochondrial enzyme (hGDH1 in the human) that catalyses the reversible inter-conversion of glutamate to α-ketoglutarate and ammonia, thus interconnecting amino acid and carbohydrate metabolism. It displays an energy sensing mechanism, which permits enzyme activation under low cellular energy states. As GDH is at the crossroads of important metabolic pathways, a tight control of its activity is essential. Indeed, to fulfill its role in metabolism and cellular energetics, mammalian GDH has evolved into a highly regulated enzyme subject to allosteric modulation by diverse compounds. The recent emergence (<23 million years ago) in apes and humans of a hGDH2 isoenzyme with distinct regulatory properties, as well as, the detection of gain-of-function variants in hGDH1 and hGDH2 that affect the nervous system, have introduced additional complexities. The properties of the two highly homologous human GDHs were studied using purified recombinant hGDH1 and hGDH2 obtained by expression of the corresponding cDNAs in Sf21 cells. Results showed that, in contrast to hGDH1 that maintains substantial basal activity (35-40% of its maximal capacity), hGDH2 displays low basal activity (3-8% of maximal) that is remarkably responsive to activation by rising levels of ADP and/or l-leucine. This is primarily due to the Arg443Ser evolutionary change, which also made hGDH2 markedly sensitive to estrogens and neuroleptic drugs. In contrast to hGDH1, which is subject to potent GTP inhibition, hGDH2 has dissociated its function from this energy switch, being able to metabolize glutamate even when the Krebs cycle generates GTP levels sufficient to inactivate the housekeeping hGDH1. Our data also show that spermidine, a polyamine thought to reduce oxidative stress and to prolong survival, and EGCG, a green tea polyphenol, inhibit hGDH2 at lower concentrations than hGDH1. The implications of these findings in nerve tissue biology are discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658952     DOI: 10.1016/j.neuint.2012.05.020

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  14 in total

1.  Localization of SUCLA2 and SUCLG2 subunits of succinyl CoA ligase within the cerebral cortex suggests the absence of matrix substrate-level phosphorylation in glial cells of the human brain.

Authors:  Arpád Dobolyi; Attila G Bagó; Aniko Gál; Mária J Molnár; Miklós Palkovits; Vera Adam-Vizi; Christos Chinopoulos
Journal:  J Bioenerg Biomembr       Date:  2014-11-05       Impact factor: 2.945

Review 2.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

3.  Glutamate metabolism in the brain focusing on astrocytes.

Authors:  Arne Schousboe; Susanna Scafidi; Lasse K Bak; Helle S Waagepetersen; Mary C McKenna
Journal:  Adv Neurobiol       Date:  2014

4.  Glutamate dehydrogenase isoforms with N-terminal (His)6- or FLAG-tag retain their kinetic properties and cellular localization.

Authors:  Kamilla Pajęcka; Camilla Wendel Nielsen; Anne Hauge; Ioannis Zaganas; Lasse K Bak; Arne Schousboe; Andreas Plaitakis; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2013-04-26       Impact factor: 3.996

Review 5.  The odyssey of a young gene: structure-function studies in human glutamate dehydrogenases reveal evolutionary-acquired complex allosteric regulation mechanisms.

Authors:  Ioannis V Zaganas; Konstantinos Kanavouras; Nikolas Borompokas; Giovanna Arianoglou; Christina Dimovasili; Helen Latsoudis; Metaxia Vlassi; Vasileios Mastorodemos
Journal:  Neurochem Res       Date:  2014-02-11       Impact factor: 3.996

6.  Transgenic Mice Carrying GLUD2 as a Tool for Studying the Expressional and the Functional Adaptation of this Positive Selected Gene in Human Brain Evolution.

Authors:  Andreas Plaitakis; Dimitra Kotzamani; Zoe Petraki; Maria Delidaki; Vagelis Rinotas; Ioannis Zaganas; Eleni Douni; Kyriaki Sidiropoulou; Cleanthe Spanaki
Journal:  Neurochem Res       Date:  2018-05-18       Impact factor: 3.996

Review 7.  Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications.

Authors:  Victoria Bunik; Artem Artiukhov; Vasily Aleshin; Garik Mkrtchyan
Journal:  Biology (Basel)       Date:  2016-12-14

Review 8.  The Glutamate Dehydrogenase Pathway and Its Roles in Cell and Tissue Biology in Health and Disease.

Authors:  Andreas Plaitakis; Ester Kalef-Ezra; Dimitra Kotzamani; Ioannis Zaganas; Cleanthe Spanaki
Journal:  Biology (Basel)       Date:  2017-02-08

Review 9.  Glutamine-Glutamate Cycle Flux Is Similar in Cultured Astrocytes and Brain and Both Glutamate Production and Oxidation Are Mainly Catalyzed by Aspartate Aminotransferase.

Authors:  Leif Hertz; Douglas L Rothman
Journal:  Biology (Basel)       Date:  2017-02-24

Review 10.  Neurointegrity and neurophysiology: astrocyte, glutamate, and carbon monoxide interactions.

Authors:  Vicki L Mahan
Journal:  Med Gas Res       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.